Nuvalent, Inc. (NUVL)

100.50 -3.56 (-3.42%) USD  |  NASDAQ  |  Feb 20, 16:00
100.39 -0.11 (-0.11%) After-Hours: 20:00
More

Nuvalent Other Cash from Operations (Quarterly)

Other Cash from Operations (Quarterly) Chart

View Other Cash from Operations (Quarterly) for NUVL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Cash from Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Cash from Operations (Quarterly) Range, Past 5 Years

View Other Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Cash from Operations (Quarterly) Benchmarks

View Other Cash from Operations (Quarterly) Benchmarks
Start Trial
Glaukos Corp. --
Edgewise Therapeutics, Inc. --
Neurocrine Biosciences, Inc. --
Vanda Pharmaceuticals, Inc. --
Kodiak Sciences, Inc. --